Weitzman Deborah
- SEC CIK
- 0001942639
In the past year, 1 open-market sale filing worth $1.73M and no purchases.
Current role at each company
- CAH Cardinal Health IncCEO, PSS Segmentas of Aug 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.73M
- 1 filing
- Net
- −$1.73M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Weitzman Deborah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)7:30 AM ET | Aug 18 | 2 days | Weitzman DeborahCEO, PSS Segment | SSale | −7.35K | $235.45 | −$1.73M | −8.6%77.9K after | 3 lots |
| Aug 20, 2025 (view filing) | Aug 20 | Same day | Weitzman DeborahCEO, PSS Segment | SSale | −21.4K | $150.53 | −$3.22M | −28.6%53.4K after | |
| Nov 29, 2023 (view filing) | Nov 27 | 2 days | Weitzman DeborahCEO, Pharmaceutical Segment | SSale | −36.6K | $106.31 | −$3.90M | −51.0%35.2K after | 10b5-1 |
| Aug 29, 2023 (view filing) | Aug 28 | 1 day | Weitzman DeborahCEO, Pharmaceutical Segment | SSale | −6.71K | $89.81 | −$602.8K | −13.2%44.2K after |